ILCA Annual Conference 2025
Hong Kong Hong Kong, ChinaILCA Annual Conference 2025 will be held from 19-21 November, 2025 at Hong Kong. The ILCA25 program will explore key topics in liver cancer, from basic and translational research to […]
ILCA Annual Conference 2025 will be held from 19-21 November, 2025 at Hong Kong. The ILCA25 program will explore key topics in liver cancer, from basic and translational research to […]
The SIOG 2025 Annual Conference will take place in person from 20 to 22 November 2025 at the International Convention Centre of Ghent (Gent ICC) in Belgium. This in-person event will […]
The ESO Refresher Course on Breast Cancer is a training program designed for medical, surgical, and radiation oncologists, pathologists, and radiologists involved in breast cancer management. Scheduled for November 21-23, […]
Hack4Hope 2025, taking place on December 3 at Futur4care, Watt-Biopark in Paris, is organized by the Paris-Saclay Cancer Cluster (PSCC) and its Childhood Cancer Working Group. Building on the success […]
ESMO Asia Congress 2025 will be held from December 5-7, 2025 at Singapore, Republic of Singapore. The congress serves as a vital platform to advance cancer care through the latest scientific discoveries, innovative therapies, and evolving clinical practices. Whether you're a clinician, researcher, or healthcare provider, this gathering offers a front-row seat to the future […]
The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event, both onsite in London, UK, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect […]
The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10, 2026, at Moscone West in San Francisco, CA, as well as online. This annual event gathers oncology professionals from around the world to explore the latest developments in GI cancer treatment, research, and patient care. Featuring cutting-edge scientific presentations and multidisciplinary discussions, the […]
The 2nd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care will be held from January 16 to 18, 2026, in Hollywood, Florida. This premier event brings together a diverse range of oncology professionals including medical oncologists, hematologists, radiation oncologists, and other healthcare providers to explore the latest developments in cancer diagnosis, treatment, and supportive […]
The NRG Oncology Winter Meeting 2026 will be held from January 22-24, 2026, at Hilton San Francisco Union Square in San Francisco, USA. This semiannual event brings together oncology researchers, clinicians, and professionals to discuss advances in clinical trials, cancer treatment protocols, translational research, and quality of life interventions. Attendees can expect a range of […]
The AACR IO Conference 2026, titled Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy, will take place from February 18–21, 2026, at JW Marriott Los Angeles L.A. Live. Led by Scientific Committee Chairs Nina Bhardwaj and Antoni Ribas, the event will focus on cutting-edge research in cancer immunology, highlighting breakthroughs in immuno-oncology (IO) […]
The 2026 ASCO Genitourinary Cancers Symposium will be held from February 26–28 at Moscone West in San Francisco. This key event will highlight the newest research, clinical updates, and evolving best practices in the management of genitourinary cancers, bringing together specialists from across oncology disciplines. The symposium’s programme will feature keynote lectures, expert panels, and […]
The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. […]